NCT03663777 Handgrip Training in Patients With Peripheral Artery Disease
| NCT ID | NCT03663777 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nove de Julho |
| Condition | Peripheral Arterial Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2018-08-01 |
| Primary Completion | 2027-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2018-08-01 with a primary completion date of 2027-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease. Will be recruited 30 patients which will be randomized into 2 groups (15 per group), IHT and control group (CG). IHT group will training isometric contraction for 12 weeks. In CG patients will be encouraged to increase the level of physical activity. In the pre and post-intervention cardiovascular measures will be obtained.
Eligibility Criteria
Inclusion Criteria: * Women in post-menopause phase without hormone replacement therapy * Ankle-brachial index \<0.90 * Not severe obese (≥ 35kg/m2) * Not present amputation in the limbs * Have blood pressure levels lower than 160mmHg for systolic and 105mmHg for diastolic Exclusion Criteria: * patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.
Contact & Investigator
Raphael Dias, PhD
PRINCIPAL INVESTIGATOR
University of Nove de Julho
Frequently Asked Questions
Who can join the NCT03663777 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Peripheral Arterial Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03663777 currently recruiting?
Yes, NCT03663777 is actively recruiting participants. Contact the research team at raphaelritti@gmail.com for enrollment information.
Where is the NCT03663777 trial being conducted?
This trial is being conducted at São Paulo, Brazil, São Paulo, Brazil.
Who is sponsoring the NCT03663777 clinical trial?
NCT03663777 is sponsored by University of Nove de Julho. The principal investigator is Raphael Dias, PhD at University of Nove de Julho. The trial plans to enroll 30 participants.